Loading company…
Sirion Biotech develops proteins, therapeutic antibodies and custom bioprocessing services.
Founded in 2006 in Germany, Sirion Biotech develops and commercializes biopharmaceutical products and services. Its offerings include recombinant proteins, monoclonal antibodies and custom bioprocessing for pharmaceutical companies, research institutions and contract manufacturers. PerkinElmer, Inc. acquired the company in June 2021 from Bayern Kapital, Creathor Ventures, High-Tech Gründerfonds, KfW Banking Group and Aumenta GmbH. Christian Thirion founded the company, and Jürgen Flach is its CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in